Dubai, UAE – May 31, 2025 — The Winter 2024 Edition of the Health 2.0 Conference was held from December 3–5, 2024, at InterContinental DFC, Dubai, UAE. The three-day health summit served as a global platform to explore emerging trends in medical technology, mental health, and patient-centered care, with discussions that bridged science, technology, and compassionate healthcare delivery. The event featured distinguished voices shaping the future of healthcare, among them was Edward Schiettecatte, Founder & CEO at BRAIN-NM Clinics.
A leader in neuropsychiatry and neurorehabilitation, the visionary behind BRAIN-NM Clinics, Edward Schiettecatte, has been at the forefront of delivering groundbreaking neuromodulation treatments for conditions such as depression, PTSD, OCD, ADHD, chronic pain, and more. Under his leadership, the clinics have earned a reputation for providing science-backed, personalized treatment plans designed and executed by award-winning neurologists and psychiatrists..
Additionally, he founded and serves as the CEO of TRAINM Clinics, one of Europe’s most advanced outpatient neurorehabilitation clinic groups. With a strong interdisciplinary approach, TRAINM combines robotics, neurogaming, VR, and neuromodulation to deliver intensive rehabilitation programs for patients with conditions such as stroke, cerebral palsy, spinal cord injury, multiple sclerosis, and disorders of consciousness.
Before venturing into healthcare, Edward Schiettecatte spent over 12 years on Wall Street in senior investment banking roles at Merrill Lynch, Rothschild, and Jefferies & Co. He also co-founded SmartFin. This leading European venture capital fund invests in high-growth technology companies. He holds an MSc in Business Engineering from Solvay Business School, Université Libre de Bruxelles, and a JD from Université Panthéon-Sorbonne, Paris 1.
During the health summit, Edward Schiettecatte delivered a powerful keynote address titled “Innovations In Neuromodulation And Mental Health.” In this session, he highlighted the rapid advancements in non-invasive neuromodulation as a transformative tool in treating mental health and neuropsychiatric disorders. He emphasized how neuromodulation techniques, when integrated into personalized care models, are creating more effective and targeted alternatives to traditional medications and therapies. He also discussed the potential of combining robotics, virtual reality (VR), and neurogaming with neuromodulation to enhance patient outcomes in both psychiatric and neurological conditions.
Edward Schiettecatte’s participation at the Health 2.0 Conference reinforced the importance of merging innovation with compassion. Edward’s journey from finance to health underscored how multidisciplinary leadership can drive real change in global healthcare delivery. His background brought a unique perspective to healthcare innovation. His keynote emphasized the potential of neuromodulation and interdisciplinary tech to enhance treatment outcomes.
The Health 2.0 Conference is a global event uniting healthcare leaders to explore innovations in digital health, wellness, and patient care. Held in Dubai and Las Vegas, it features expert speakers, networking opportunities, and discussions on emerging technologies and policy shifts. Attendees include professionals from healthcare, life sciences, and biotech sectors, aiming to drive impactful change and collaboration in the evolving healthcare landscape. To learn more about the upcoming editions of this health conference, please visit www.health2conf.com.